Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.

Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Princess Margaret Cancer Centre, Canada.

Dr. James Chun Lam Chow, PhD, FCCPM, FInstP, FIET, SMIEEE, PPhys, CPhys, CSci, is a distinguished medical physicist specializing in radiation oncology and artificial intelligence applications in healthcare. He is currently an Associate Professor in Material Science and Engineering at the University of Toronto and a Clinician Investigator at the Princess Margaret Cancer Research Institute. With over two decades of experience in medical physics, his research focuses on AI-driven healthcare solutions, radiation therapy optimization, and Monte Carlo simulations for cancer treatment.

Profile

Google Scholar

Education🎓

Dr. James C. L. Chow earned his PhD in Physics from the University of Hong Kong in 1995 under the supervision of Prof. Peter Fung, following a BSc in Applied Physics (First Class Honours) from City University of Hong Kong in 1992. He was awarded a Croucher Postdoctoral Fellowship at the University of Cambridge (1995-1997), then continued his research as a Postdoctoral Researcher at the University of Toronto (1997-1998) and later as a Postdoctoral Fellow at McMaster University (1998-2000). Transitioning into medical physics, he completed his Medical Physics Residency at the London Regional Cancer Centre (2000-2002), gaining clinical expertise in radiation therapy and medical imaging.

Professional Experience🌟

Dr. James C. L. Chow is an accomplished medical physicist and academic with extensive experience in radiation oncology and materials science. He is currently an Associate Professor in the Department of Materials Science and Engineering at the University of Toronto (2025–Present) and has been an Associate Professor in the Department of Radiation Oncology at the University of Toronto since 2019. In addition to his academic roles, he serves as a Medical Physicist at Princess Margaret Cancer Centre (2005–Present), where he also leads as the Physics On-Call Lead (2010–Present). His research contributions are further reflected in his role as a Clinician Investigator at the Princess Margaret Cancer Research Institute (2023–Present) and his affiliation with the Acceleration Consortium at the University of Toronto (2024–Present).

Previously, Dr. Chow held multiple key positions, including Assistant Professor in Radiation Oncology at the University of Toronto (2006–2019) and Medical Physics Site Lead for Skin Cancer at Princess Margaret Cancer Centre (2010–2015). Before joining Princess Margaret, he worked as a Medical Physicist and Deputy Radiation Safety Officer at Grand River Regional Cancer Centre (2002–2005). He has also contributed to academia as an Adjunct Professor at Ryerson University and the University of Waterloo (2005–2010). His career reflects a deep commitment to advancing medical physics, cancer treatment, and interdisciplinary research in materials science and engineering.

Research Interests📚

Dr. Chow’s research focuses on:

Radiation Oncology & Medical Physics: Treatment optimization using Monte Carlo simulations

Artificial Intelligence in Healthcare: AI-driven diagnostic tools and chatbot applications in oncology

Nanotechnology in Radiation Therapy: Gold nanoparticle-enhanced radiotherapy

Clinical Data Analysis: Predictive modeling for cancer treatment outcomes

Awards & Recognitions🏆

2024 Outstanding Reviewer, Nuclear Engineering and Technology Journal

2024 Most-Viewed Article, JMIR Cancer

2024 Outstanding Author of the Year, AIMS Biophysics Journal

2019 Top Peer Reviewer, Web of Science Group

2012 Outstanding Reviewer, Medical Physics Journal

2010 SciNet Local Resource Allocation Award (1 million supercomputing hours for Monte Carlo simulations)

Selected Publications📖

Gold nanoparticles for drug delivery and cancer therapy
S Siddique, JCL Chow
Applied Sciences 10(11), 3824 (2020) – Cited: 382

Chatbot for health care and oncology applications using artificial intelligence and machine learning: Systematic review
L Xu, L Sanders, K Li, JCL Chow
JMIR Cancer 7(4), e27850 (2021) – Cited: 375

Application of nanomaterials in biomedical imaging and cancer therapy
S Siddique, JCL Chow
Nanomaterials 10(9), 1700 (2020) – Cited: 325

Irradiation of gold nanoparticles by X‐rays: Monte Carlo simulation of dose enhancements and the spatial properties of secondary electron production
MKK Leung, JCL Chow, BD Chithrani, MJG Lee, B Oms, DA Jaffray
Medical Physics 38(2), 624-631 (2011) – Cited: 311

Machine learning in healthcare communication
S Siddique, JCL Chow
Encyclopedia 1(1), 220-239 (2021) – Cited: 142

 

 

Dr. Amy Miner Ross | Immunology | Best Innovation Award

Dr. Amy Miner Ross | Immunology | Best Innovation Award

OHSU, United States.

Dr. Amy Miner Ross, Ph.D., R.N., C.N.S., is an esteemed nursing scholar and educator at Oregon Health & Science University (OHSU) School of Nursing. With a rich background in neuroscience nursing, critical care, and health systems leadership, she has significantly contributed to research on inflammatory response in stroke/TIA and work environments in nursing. Over the years, Dr. Ross has received multiple prestigious awards, served in key academic leadership roles, and has been an advocate for evidence-based nursing practice and education.

Profile

Scopus
Google Scholar

📚 Education

Dr. Amy Miner Ross holds a Ph.D. in Nursing from Oregon Health & Science University (2006), where her research focused on the inflammatory response in stroke and transient ischemic attacks (TIA). She earned an M.S. in Nursing from the University of California, San Francisco (1987), specializing in Physiological Nursing and Physiology. Her academic foundation includes a B.S. in Nursing from the University of San Francisco (1978) and an A.S. in Science from City College of San Francisco (1974). With a strong background in nursing education and research, Dr. Ross has made significant contributions to the understanding of physiological responses in critical health conditions.

👩‍🏫 Professional Experience

Dr. Amy Miner Ross is an Associate Professor at the Oregon Health & Science University (OHSU) School of Nursing, where she has been a faculty member since 2006. She has held various leadership roles, including Interim Director of the Doctor of Philosophy Program (2020–2022) and Director of Health Systems & Organizational Leadership (2014–2024). From 2006 to 2012, she was also a faculty member in the Doctor of Nursing Practice Program.

Beyond academia, Dr. Ross has extensive clinical and research experience. She served as a Research Consultant & Director of Professional Development at Asante Health System (2005–2008) and worked as a Neuroscience Clinical Nurse Specialist at Rogue Valley Medical Center (2003–2006). Earlier in her career, she was a Clinical Nurse Specialist in Neurosurgery Research at the University of California, San Francisco (1983–1989), contributing to advancements in neurosurgical care and research.

🔬 Research Interests

Dr. Ross's research focuses on:

Inflammatory response in stroke/TIA

Peripheral immune response trajectories in stroke patients

Work environments & nursing care quality

Health systems leadership & nursing education

She has been involved in NIH-funded research and has received grants for projects investigating stroke immunology, healthcare environments, and virtual reality applications in nursing.

🏆 Awards & Honors

OHSU SON Excellence in Teaching Award (2023)

OHSU Graduate Faculty Recognition Award (2023, 2016)

FLAME Award – Faculty Mentor Nominee (2023)

Sakai Inclusivity Award – OHSU Teaching Learning Center (2022)

Top Downloaded Paper Award – Journal of Nursing Scholarship (2018-2019)

Neuroscience Nursing Foundation New Investigator Award (2013)

Pan American Games Gold Medalist – Synchronized Swimming (1971)

📄 Selected Publications

Liu, J., You, L., Zheng, J., Ross, A.M., & Liu, K. (2016). Effects of work environments on the quality of care in ICUs: a multisite study in China. Journal of Nursing Care Quality. PMID: 26796973 [Cited 25 times]

Ross, A. M., Lee, C. S., & Lutsep, H. (2015). Influence of Gender and Age on the Peripheral Immune Response in Stroke. Journal of Cardiovascular Nursing. PMID: 25774839 [Cited 6 times]

Ross, A. M. & Lee, C. S. (2015). Description and identification of the peripheral immune response trajectories over time in first-time & recurrent stroke/TIA. Journal of Neuroscience Nursing, 47(5), 256-262. PMID: 26236950 [Cited 3 times]

Li, K., Yan, T., You, L., Li, R., & Ross, A. M. (2015). International classification of functioning, disability and health categories for spinal cord injury nursing in China. Disability and Rehabilitation, 37(1), 25-32. PMID: 24564326 [Cited 15 times]

 

 

 

Prof. Huasong Ai | Chemical Biology | Best Researcher Award

Prof. Huasong Ai | Chemical Biology | Best Researcher Award

Shanghai Jiao Tong University, China.

Prof. Huasong Ai is an Associate Professor at the School of Pharmaceutical Science, Shanghai Jiao Tong University, China. His research focuses on epigenetic mechanisms, chemical biology, and nucleosome modifications. With a strong background in organic chemistry and pharmacy, he has pioneered innovative methods in histone modification synthesis and chromatin ubiquitination studies. Prof. Ai has published 28 research papers, including 13 as the first or corresponding author in prestigious journals such as Nature Chemical Biology, Molecular Cell, and JACS. He is a recipient of multiple academic honors, including the Tsinghua University Excellent Doctoral Dissertation Award and Innovation Award.

Profile

Scopus
Orcid

🎓 Education

Prof. Huasong Ai earned his Ph.D. in Organic Chemistry from Tsinghua University (2017–2022) under the mentorship of Prof. Lei Liu. His doctoral research focused on epigenetic mechanisms and chemical synthesis of post-translationally modified nucleosomes, contributing to advancements in histone modification studies. Prior to his Ph.D., he completed his Bachelor’s Degree in Pharmacy at Tsinghua University, School of Pharmacy (2013–2017), where he built a strong foundation in pharmaceutical sciences, drug development, and organic chemistry. His academic journey has equipped him with interdisciplinary expertise in chemical biology, molecular mechanisms, and structural biochemistry.

💼 Work Experience

Prof. Huasong Ai is currently an Associate Professor at Shanghai Jiao Tong University, where he leads cutting-edge research in epigenetics, chemical biology, and nucleosome modifications. Prior to this, he served as an Assistant Researcher and Postdoctoral Fellow at Tsinghua University (2022–Present), working under Prof. Lei Liu to develop novel chemical synthesis methods for studying post-translational modifications of histones and chromatin dynamics.

His research experience also includes international collaborations. In 2023, he was a Visiting Scholar at Shanghai Jiao Tong University, where he expanded his work on biochemical and structural mechanisms of epigenetic effectors. Additionally, in 2019, he conducted research as a Visiting Scholar at the University of Chicago, working with Prof. Minglei Zhao on advanced molecular biology techniques to study histone ubiquitination and its role in gene regulation.

🔍 Research Interests

Prof. Ai’s research focuses on epigenetic effectors and post-translational modifications of nucleosomes, particularly in:

🔬 Chemical synthesis of modified histones/nucleosomes

🧬 Chromatin ubiquitination mechanisms

⚛️ Structural and biochemical analysis of epigenetic regulators
His innovative work has led to breakthroughs in histone modification studies and protein regulation mechanisms.

🏆 Awards & Honors

Tsinghua University High-Level Young Talent Program "Shuimu Scholar"

Tsinghua University Excellent Doctoral Dissertation Award 🏅

Three-time recipient of Tsinghua University Postdoctoral Excellence Award 🎖️

China Postdoctoral Science Foundation (Special & General Funding)

Journal ReviewerNature Chemical Biology, Nature Structural & Molecular Biology

📚 Selected Publications

1️⃣ The Emerging Role of the Histone H2AK13/15 Ubiquitination: Mechanisms of Writing, Reading, and Erasing in DNA Damage Repair and Disease
📌 Cells, 2025-02-18

2️⃣ Promotion of RNF168-Mediated Nucleosomal H2A Ubiquitylation by Structurally Defined K63-Polyubiquitylated Linker Histone H1
📌 Angewandte Chemie International Edition, 2025-01-02

3️⃣ Promotion of RNF168-Mediated Nucleosomal H2A Ubiquitylation by Structurally Defined K63-Polyubiquitylated Linker Histone H1
📌 Angewandte Chemie, 2025-01-02

4️⃣ Structural and Mechanistic Basis for Nucleosomal H2AK119 Deubiquitination by Single-Subunit Deubiquitinase USP16
📌 Nature Structural & Molecular Biology, 2024-11

5️⃣ Mechanism of Nucleosomal H2A K13/15 Monoubiquitination and Adjacent Dual Monoubiquitination by RNF168
📌 Nature Chemical Biology, 2024-10-11